NEW YORK (GenomeWeb) – Twist Bioscience announced today that it has raised $27 million in venture financing, completing a $60 million financing it began in March.

The new funding includes a key investment from Biomatics Capital as well as new investors Reinet Fund, NFT Investment Limited, Kangmei Group, Bay City Capital GF Xinde Life Science Investment Fund, 3W Partners Capital, and Ditch Plains Capital Management.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.